Vitreoretinal morphology in active ocular toxoplasmosis: A prospective study by optical coherence tomography

British Journal of Ophthalmology

Volumn 91, Issue 6, 2007, Pages 773-780

  Oréfice, Juliana L ^b   Costa, Rogério A ^a   Oréfice, Fernando ^b   Campos, Wesley ^b   Da Costa Lima Jr , Décio ^b   Scott, Ingrid U ^c  

^a Hospital de Olhos de Araraquara   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; PREDNISOLONE; PYRIMETHAMINE; SULFADIAZINE; VISUAL PIGMENT;

ADOLESCENT; ADULT; ARTICLE; CHOROID CAPILLARY LAYER; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA CELL; RETINA INJURY; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA MACULOPATHY; SCHOOL CHILD; TOXOPLASMOSIS; VITREORETINOPATHY; VITREOUS BODY; VITREOUS BODY DETACHMENT;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TOXOPLASMOSIS, OCULAR; VITREOUS BODY;

EID: 34249776672     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.108068     Document Type: Article

References (29)

1. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology, UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996;121:35-46.
2. Oréfice F. Toxoplasmose. In: Oréfice F, eds. Uveíte clínica e cirúrgica:Texto e Atlas. 2nd edn. Rio de Janeiro: Cultura Médica, 2005:708-9.
3. Garcia CA, Oréfice F, Lyra CO, et al. Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in northeastern Brazil. Ophthalmic Epidemiol 2004;11:301-17.
4. Foster CS, Vitale AT. Toxoplasmosis. In: Vitale AT, eds. Diagnosis and treatment of uveitis. Philadelphia: WB Saunders Company, 2001:389-97.
5. Holland GN, O'Connor GR, Belfort R Jr, et al. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection & immunity. St Louis, MO: Mosby-Year Book, 1996:1183-223.
6. Hogan MJ, Kimura SJ, O'Connor GR. Ocular toxoplasmosis. Arch Ophthalmol 1964;72:592-600.
7. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81:481-93.
8. O'Connor GR. Manifestations and management of ocular toxoplasmosis. Bull N Y Acad Med 1974;50:192-210.
9. Willerson Jr D, Aaberg TM, Reeser F, et al. Unusual ocular presentation of acute toxoplasmosis. Br J Ophthalmol 1977;61:693- 8.
10. Smith JR, Cunningham ET. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 2002;13:387-92.
11. Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 2002;134:196-203.
12. Moshfeghi DM, Lowder CY, Dodds EM, et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 2004;111:716-25.
13. Balansard B, Bodaghi B, Cassoux N, et al. Necrotising retinopathies simulating acute retinal necrosis syndrome. Br J Ophthalmol 2005;89:96-101.
14. Doft BH, Gass JDM. Punctate outer retinal toxoplasmosis. Arch Ophthalmol 1985;103:1332-6.
15. Matthews JD, Weiter JJ. Outer retinal toxoplasmosis. Ophthalmology 1988;95:941-6.
16. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003;136:973- 88.
17. Lebech M, Johnson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
18. Stanford MR, Tan HK, Gilbert R, Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol 2006;90:1464-7.
19. Jabs DA, Nussemblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomeclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140:509-16.
20. Schlaegel TF Jr, Weber JC. The macula in ocular toxoplasmosis. Arch Ophthalmol 1984;102:697-8.
21. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 2004;137:1-17.
22. Lieb DF, Scott IU, Flynn HW, et al. Acute acquired toxoplasma retinitis may present similarly to unilateral acute idiopathic maculopathy. Am J Ophthalmol 2004;137:940-2.
23. Oréfice JL, Costa RA, Campos W, et al. Third-generation optical coherence tomography findings in punctate retinal toxoplasmosis. Am J Ophthalmol 2006;142:503-5.
24. Labalette P, Delhaes L, Margaron F, et al. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 2002;133:506-15.
25. Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 1996;80:1099-107.
26. Stanford MR, Tomlin EA, Comyn O, et al. The visual field in toxoplasmic retinochoroiditis. Br J Ophthalmol 2005;89:812-14.
27. Bosch-Driesssen EH, Berendschot TJM, Ongkosuwito JV, et al. Ocular toxoplasmosis clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78.
28. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis [published erratum in Am J Ophthalmol. 2002;134: 944], Am J Ophthalmol 2002;134:102-14.
29. de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 2003;87:879-84.